Applying to Clinical Trial: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.

Contact this trialFirst, we need to learn more about you.

Psychedelic

Psilocybin for Major Depressive Disorder

Recruiting1 awardPhase 2

Baltimore, Maryland

This trial is testing whether psilocybin, a compound from 'magic mushrooms,' can help improve depression in adults with Bipolar II Disorder. The idea is that psilocybin changes brain chemistry to improve mood. Psilocybin has shown promise as a treatment for major depressive disorder and was recognized by the FDA in 2019.

Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.

We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our and .

Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.

By clicking start, you agree to our